SPDR S&P Pharmaceuticals ETF
In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the pharmaceuticals segment of the S&P Total Market Index ("S&P TMI").
SOURCE: MARKET TAPE & DAILY CREATION/REDEMPTION RECORDS · 1Y SHOWN · NET +$247M OVER THIS RANGE
Money keeps arriving — +$56M of net buying over the past month, about 10.0% of the fund's asset base, while the price has returned +31.9% so far this year. At 0.35% a year it is not the cheapest way in — IWM runs the same ground at 0.19%.
COMPOSED FROM THE FUND’S OWN DAILY RECORDS · UPDATED WITH EACH REFRESH
| 1 week | +2.6% |
| 1 month | +6.3% |
| 3 months | +26.0% |
| 6 months | +26.8% |
| YTD | +31.9% |
| 1 year | +53.8% |
| 3 years | — |
PRICE RETURN, DISTRIBUTIONS NOT REINVESTED
| 1 week | +$14M |
| 1 month | +$56M |
| 3 months | +$118M |
| YTD | +$230M |
| 1 year | +$247M |
CREATION/REDEMPTION DOLLARS, DAILY RECORDS
VOLATILITY & DRAWDOWN FROM THE DAILY TAPE · CONCENTRATION FROM THE LATEST DISCLOSED BOOK